Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
Titel:
Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
Auteur:
Lorente, D. Mateo, J. Templeton, A.J. Zafeiriou, Z. Bianchini, D. Ferraldeschi, R. Bahl, A. Shen, L. Su, Z. Sartor, O. de Bono, J.S.